Nanobiotix S.A.
NANO.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | – | €0 | €0 | €0 |
| - Cash | €0 | €0 | €0 | €0 |
| + Debt | €0 | €0 | €0 | €0 |
| Enterprise Value | – | €0 | €0 | €0 |
| Revenue | €0 | -€0 | €0 | €0 |
| % Growth | 227.5% | -325% | -71.8% | – |
| Gross Profit | €0 | -€0 | €0 | €0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | €0 | -€0 | -€0 | -€0 |
| % Margin | 4.1% | 212.6% | -250.2% | -15% |
| Net Income | -€0 | -€0 | -€0 | -€0 |
| % Margin | -20.2% | 221.4% | -235.5% | -35.2% |
| EPS Diluted | -0.11 | -0.98 | -0.46 | -0.3 |
| % Growth | 88.8% | -113% | -53.3% | – |
| Operating Cash Flow | -€0 | -€0 | -€0 | €0 |
| Capital Expenditures | -€0 | -€0 | -€0 | -€0 |
| Free Cash Flow | -€0 | -€0 | -€0 | €0 |